Pivotal Therapeutics Inc.
PVTTF
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 21.17% | -111.82% | 159.96% | 31.12% | 13.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.17% | -111.82% | 159.96% | 31.12% | 13.65% |
| Cost of Revenue | 4.95% | -34.67% | -43.53% | 3.60% | -56.47% |
| Gross Profit | 24.07% | -164.27% | 446.97% | 6.05% | 59.60% |
| SG&A Expenses | -49.13% | -70.82% | -53.86% | 45.12% | 42.08% |
| Depreciation & Amortization | 7.94% | 16.06% | 36.71% | 18.56% | 117.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -51.71% | -67.25% | -49.21% | 20.09% | 102.54% |
| Operating Income | 56.61% | 65.61% | 56.80% | -19.17% | -113.75% |
| Income Before Tax | 45.87% | 40.62% | 34.24% | 103.45% | -216.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.87% | 40.62% | 34.24% | 103.57% | -216.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.87% | 40.62% | 34.24% | 103.57% | -216.07% |
| EBIT | 56.61% | 65.61% | 56.80% | -19.17% | -113.75% |
| EBITDA | 58.29% | 66.73% | 58.30% | -19.18% | -113.66% |
| EPS Basic | 47.85% | 42.40% | 35.22% | 104.00% | -171.67% |
| Normalized Basic EPS | 48.04% | 42.22% | 36.00% | 103.08% | -175.68% |
| EPS Diluted | 47.85% | 42.40% | 35.22% | 104.00% | -171.67% |
| Normalized Diluted EPS | 48.04% | 42.22% | 36.00% | 103.08% | -175.68% |
| Average Basic Shares Outstanding | 3.43% | 3.37% | 1.95% | 1.21% | 15.69% |
| Average Diluted Shares Outstanding | 3.43% | 3.37% | 1.95% | 1.21% | 15.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |